FIREX | VGRNX | FIREX / VGRNX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 20 years | 14 years | - |
Gain YTD | 3.941 | 2.752 | 143% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 5000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 294M | 3.33B | 9% |
Annual Yield % from dividends | 1.92 | 3.78 | 51% |
Returns for 1 year | 0.36 | 3.66 | 10% |
Returns for 3 years | -24.78 | -16.05 | 154% |
Returns for 5 years | -21.42 | -20.27 | 106% |
Returns for 10 years | -1.96 | -1.43 | 138% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
RYWUX | 66.05 | 1.33 | +2.06% |
Rydex Emerging Markets 2X Strategy C | |||
NQGAX | 36.33 | -0.37 | -1.01% |
Nuveen Global Equity Income A | |||
ETIHX | 35.38 | -0.37 | -1.03% |
Eventide Healthcare & Life Sciences I | |||
GSLAX | 16.33 | -0.24 | -1.45% |
Goldman Sachs Large Cap Value A | |||
OLVRX | 20.83 | -0.44 | -2.07% |
JPMorgan Large Cap Value R4 |